You are here



The call for elections to choose the board of directors will open on 9 January



Presentació estudi CataloniaBio i EY

Most of the funding comes from inside Catalonia, through venture capital funds, licensing deals and business angels and family offices, according to study from CataloniaBio and EY

Banner de l'ASEBIO Investor Day 2017

The deadline to sign up for ASEBIO Investor Day is 30 June

Josep Castells Inkemia

InKemia, which now has a network of 14 companies in the healthcare sector, is creating a new fund for start-ups and spin-offs

Marc Martinell

The drug, called MIN-102 and used to treat adrenoleukodystrophy, has also recently been granted this designation from the European Medicines Agency

Joan Bertran

Thanks to the participation of social impact investors, the company can continue to focus their therapies on pediatrics

Parc Tecnològic Vallès

The product, Zelium, is a therapeutic alternative for treating a serious complication in diabetic patients

SOM Biotech

The company will use this capital to grow in the United States and fund a clinical trial on its repositioned drug to treat Huntington disease 

Transplant Biomedicals

Caixa Capital Risc and Kereon Partners have invested in this spin-off created through technology transfer from IDIBAPS-Hospital Clínic de Barcelona

Bionure Estamosaesto

The biotech firm has opened a crowdequity round of funding on the Capital Cell platform and has created a campaign on social media